Non-Hodgkin Lymphoma | Specialty

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

CAR-T Leads Advances Across Lymphomas, But Further Research Needed

February 25th 2020

Dimitrios Tzachanis, MD, PhD, discusses updates and remaining questions with CAR T-cell therapy.

Novel Approaches Under Exploration Across Lymphoma Subtypes

February 24th 2020

Erin Reid, MD, discusses the treatment advances across lymphomas and the remaining questions that need to be answered with further research.

Future Directions and Unmet Needs for Treatment of DLBCL

January 30th 2020

Emerging Agents in the Management of R/R DLBCL

January 30th 2020

L-MIND Trial in Relapsed/Refractory DLBCL

January 30th 2020

Future Directions of CAR T Therapy in R/R DLBCL

January 30th 2020

R/R DLBCL: CAR T Therapy and Immune Checkpoint Inhibition

January 30th 2020

Safety and Efficacy of CAR T Therapy in R/R DLBCL

January 30th 2020

Use of CAR T Therapy in R/R DLBCL

January 30th 2020

Treatment Alternatives to Chemotherapy in R/R DLBCL

January 30th 2020

Management of Relapsed/Refractory DLBCL

January 30th 2020

Role of CNS Prophylaxis in DLBCL

January 30th 2020

Optimization of PET Scans and Determining Relapse in DLBCL

January 30th 2020

Comorbidities and Role of R-CHOP in DLBCL

January 30th 2020

Prognostic Factors in DLBCL

January 30th 2020

Treatment of Newly Diagnosed DLBCL

January 30th 2020

The Future Landscape of Follicular Lymphoma Treatment

January 28th 2020

Phase Ib Polatuzumab Vedotin Trial

January 28th 2020

The Phase III GADOLIN Trial

January 28th 2020

Previously Untreated FL: Obinutuzumab Plus Lenalidomide

January 28th 2020